← Back to Search

Oral Rinse

MucoPEG for Dry Mouth Syndrome (CEMPEG Trial)

N/A
Waitlist Available
Led By To be determined To be determined, DDS
Research Sponsored by SunBio, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 hours and 1 week of use
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing two different mouth rinses, MucoPEG™ and Biotene®, to see which one works better for people with dry mouth. The study involves 42 patients who will use each rinse for a short period. The goal is to find out which rinse helps keep the mouth moist and comfortable. Biotene® is a widely used product for managing dry mouth symptoms.

Eligible Conditions
  • Dry Mouth Syndrome
  • Dry Mouth
  • Xerostomia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 hours and 1 week of use
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 hours and 1 week of use for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Dry Mouth Relief Questionnaires (DMRQ)
Secondary study objectives
Change in Xerostomia using the Dry Mouth Inventory (DMI) questionnaire.
Number of participants with treatment-related adverse events as evaluated by the Principal Investigator
Product Performance and Attributes Questionnaire (PPAQ)
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: MucoPEGExperimental Treatment1 Intervention
Arm being compared to against Biotene
Group II: BioteneActive Control1 Intervention
Arm being compared against MucoPEG
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MucoPEG
2022
N/A
~50

Find a Location

Who is running the clinical trial?

RudacureIndustry Sponsor
SunBio, Inc.Lead Sponsor
NAMSAOTHER
52 Previous Clinical Trials
20,651 Total Patients Enrolled
~12 spots leftby Nov 2025